SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review
Standard
SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review. / Afshar, Zeinab Mohseni; Barary, Mohammad; Babazadeh, Arefeh; Hosseinzadeh, Rezvan; Alijanpour, Amirmasoud; Miri, Seyed Rouhollah; Sio, Terence T; Sullman, Mark J M; Carson-Chahhoud, Kristin; Langer, Florian; Ebrahimpour, Soheil.
In: REV MED VIROL, Vol. 32, No. 4, e2327, 07.2022.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review
AU - Afshar, Zeinab Mohseni
AU - Barary, Mohammad
AU - Babazadeh, Arefeh
AU - Hosseinzadeh, Rezvan
AU - Alijanpour, Amirmasoud
AU - Miri, Seyed Rouhollah
AU - Sio, Terence T
AU - Sullman, Mark J M
AU - Carson-Chahhoud, Kristin
AU - Langer, Florian
AU - Ebrahimpour, Soheil
N1 - © 2022 John Wiley & Sons Ltd.
PY - 2022/7
Y1 - 2022/7
N2 - Since the start of the pandemic, thrombotic events have been a well-known and severe complication associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nevertheless, the initiation of vaccination programs brought another rare yet highly fatal thrombotic event, vaccine-induced immune thrombotic thrombocytopaenia, which has caused extensive debate regarding the safety of vaccines. This review defines the thromboembolic events following infection and vaccination, identifies their risk factors, describes their pathophysiology, and discusses their management, treatment, and prevention.
AB - Since the start of the pandemic, thrombotic events have been a well-known and severe complication associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nevertheless, the initiation of vaccination programs brought another rare yet highly fatal thrombotic event, vaccine-induced immune thrombotic thrombocytopaenia, which has caused extensive debate regarding the safety of vaccines. This review defines the thromboembolic events following infection and vaccination, identifies their risk factors, describes their pathophysiology, and discusses their management, treatment, and prevention.
U2 - 10.1002/rmv.2327
DO - 10.1002/rmv.2327
M3 - SCORING: Review article
C2 - 35112763
VL - 32
JO - REV MED VIROL
JF - REV MED VIROL
SN - 1052-9276
IS - 4
M1 - e2327
ER -